News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
392,625 Results
Type
Article (18897)
Company Profile (112)
Press Release (373608)
Multimedia
Podcasts (73)
Webinars (13)
Section
Business (118625)
Career Advice (518)
Deals (20640)
Drug Delivery (73)
Drug Development (51682)
Employer Resources (55)
FDA (8726)
Job Trends (8342)
News (202608)
Policy (17805)
Tag
Academia (917)
Accelerated approval (14)
Adcomms (10)
Allergies (84)
Alliances (27154)
ALS (102)
Alzheimer's disease (990)
Antibody-drug conjugate (ADC) (193)
Approvals (8999)
Artificial intelligence (325)
Autoimmune disease (73)
Automation (19)
Bankruptcy (192)
Best Places to Work (6472)
BIOSECURE Act (9)
Biosimilars (139)
Biotechnology (45)
Bladder cancer (113)
Brain cancer (41)
Breast cancer (411)
Cancer (3118)
Cardiovascular disease (259)
Career advice (459)
Career pathing (13)
CAR-T (123)
CDC (7)
Cell therapy (360)
Cervical cancer (27)
Clinical research (45782)
Collaboration (1021)
Company closure (1)
Compensation (578)
Complete response letters (34)
COVID-19 (1079)
CRISPR (53)
C-suite (500)
Cystic fibrosis (91)
Data (4069)
Denatured (18)
Depression (59)
Diabetes (236)
Diagnostics (2737)
Digital health (22)
Diversity (3)
Diversity, equity & inclusion (16)
Drug discovery (134)
Drug pricing (119)
Drug shortages (13)
Duchenne muscular dystrophy (126)
Earnings (56071)
Editorial (30)
Employer branding (4)
Employer resources (49)
Events (71844)
Executive appointments (726)
FDA (10518)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (8)
Funding (804)
Gene editing (113)
Generative AI (21)
Gene therapy (316)
GLP-1 (553)
Government (2063)
Grass and pollen (7)
Guidances (282)
Healthcare (7713)
HIV (31)
Huntington's disease (17)
IgA nephropathy (59)
Immunology and inflammation (126)
Immuno-oncology (20)
Indications (58)
Infectious disease (1199)
Inflammatory bowel disease (116)
Inflation Reduction Act (10)
Influenza (45)
Intellectual property (139)
Interviews (70)
IPO (9490)
IRA (33)
Job creations (2244)
Job search strategy (408)
Kidney cancer (12)
Labor market (28)
Layoffs (242)
Leadership (10)
Legal (4153)
Liver cancer (56)
Longevity (9)
Lung cancer (498)
Lymphoma (247)
Machine learning (27)
Management (19)
Manufacturing (457)
MASH (107)
Medical device (4549)
Medtech (4563)
Mergers & acquisitions (11826)
Metabolic disorders (647)
Multiple sclerosis (101)
NASH (21)
Neurodegenerative disease (179)
Neuropsychiatric disorders (42)
Neuroscience (1697)
NextGen: Class of 2025 (2570)
Non-profit (1402)
Now hiring (18)
Obesity (293)
Opinion (154)
Ovarian cancer (91)
Pain (137)
Pancreatic cancer (125)
Parkinson's disease (174)
Partnered (11)
Patents (274)
Patient recruitment (222)
Peanut (27)
People (34779)
Pharmaceutical (64)
Pharmacy benefit managers (18)
Phase I (12395)
Phase II (19709)
Phase III (16905)
Pipeline (2623)
Policy (138)
Postmarket research (1817)
Preclinical (5247)
Press Release (32)
Prostate cancer (165)
Psychedelics (20)
Radiopharmaceuticals (171)
Rare diseases (479)
Real estate (3098)
Recruiting (19)
Regulatory (13935)
Reports (20)
Research institute (1012)
Resumes & cover letters (66)
Rett syndrome (19)
RNA editing (5)
RSV (34)
Schizophrenia (95)
Series A (133)
Series B (94)
Service/supplier (5)
Sickle cell disease (75)
Special edition (13)
Spinal muscular atrophy (94)
Sponsored (17)
Startups (1897)
State (2)
Stomach cancer (14)
Supply chain (64)
Tariffs (72)
The Weekly (53)
Vaccines (383)
Venture capital (44)
Weight loss (178)
Women's health (40)
Worklife (4)
Date
Today (75)
Last 7 days (370)
Last 30 days (1558)
Last 365 days (20971)
2025 (20461)
2024 (21185)
2023 (22676)
2022 (29202)
2021 (30376)
2020 (28602)
2019 (22777)
2018 (17607)
2017 (18796)
2016 (17942)
2015 (21501)
2014 (16972)
2013 (13849)
2012 (14917)
2011 (15715)
2010 (14235)
Location
Africa (373)
Alabama (36)
Alaska (2)
Arizona (114)
Arkansas (6)
Asia (25469)
Australia (3683)
California (6875)
Canada (2059)
China (740)
Colorado (289)
Connecticut (314)
Delaware (244)
Europe (54816)
Florida (942)
Georgia (191)
Hawaii (2)
Idaho (19)
Illinois (551)
India (45)
Indiana (330)
Iowa (7)
Japan (318)
Kansas (82)
Kentucky (25)
Louisiana (9)
Maine (23)
Maryland (798)
Massachusetts (5174)
Michigan (134)
Minnesota (330)
Mississippi (3)
Missouri (97)
Montana (10)
Nebraska (9)
Nevada (65)
New Hampshire (23)
New Jersey (2037)
New Mexico (11)
New York (1763)
North Carolina (855)
North Dakota (4)
Northern California (3265)
Ohio (170)
Oklahoma (9)
Oregon (20)
Pennsylvania (1257)
Puerto Rico (13)
Rhode Island (20)
South America (590)
South Carolina (14)
Southern California (2735)
Tennessee (101)
Texas (1042)
United States (24255)
Utah (168)
Vermont (1)
Virginia (215)
Washington D.C. (55)
Washington State (554)
West Virginia (2)
Wisconsin (79)
Wyoming (1)
392,625 Results for "purdue pharmaceuticals l p".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Purdue Pharma L.P. Awards Grant for Investigator-initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection
Purdue Pharma L.P. (“Purdue”) announced today that the Company has awarded an investigator-initiated research (IIR) grant to a team of researchers at The University of New Mexico (UNM) for the evaluation of nalmefene hydrochloride (HCl) injection 2mg/2mL (1mg/1mL) in the emergency department setting.
March 27, 2024
·
7 min read
Press Releases
Vanda Pharmaceuticals Announces Participation in the J.P. Morgan Healthcare Conference
December 12, 2025
·
1 min read
Bankruptcy
Purdue Files for Bankruptcy Anew to Support $7.4B+ Opioid Settlement
The Supreme Court last year blocked a previous settlement proposal from Purdue, arguing that the plan would afford the Sackler family too much protection.
March 20, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Madrigal Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 16, 2025
·
1 min read
Press Releases
Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 16, 2025
·
2 min read
Press Releases
ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress 2025
December 8, 2025
·
8 min read
Press Releases
KalVista Pharmaceuticals Announces Appointment of Bethany L. Sensenig to Board of Directors
October 2, 2025
·
4 min read
Press Releases
Lilly plans to expand Purdue University collaboration with up to a $250 million investment to accelerate pharmaceutical innovation
May 12, 2025
·
5 min read
Press Releases
ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and Previously Treated NSCLC Patients with EGFR Atypical Mutations at the ESMO Asia Congress 2025
December 5, 2025
·
8 min read
Pharm Country
Purdue Pharma L.P. to Provide Funding Opportunities for Investigator-Initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection
Purdue Pharma L.P. is accepting proposals for investigator-initiated research (IIR) to examine the outcomes associated with the use of Nalmefene Hydrochloride injection, 2mg/2mL (1mg/1mL).
March 28, 2023
·
6 min read
1 of 39,263
Next
